china

  1. Chandelier

    A retrospective study on the impact of SARS-CoV-2 infection on cardiopulmonary function in a healthy Chinese cohort: a focus on long COVID, 2026, Chen

    A retrospective study on the impact of SARS-CoV-2 infection on cardiopulmonary function in a healthy Chinese cohort: a focus on “long COVID” Chen, Yingzhe; Li, Rui; Zhang, Zhuhua Abstract Objective: This retrospective study aimed to observe the cardiopulmonary function and lingering symptoms...
  2. Chandelier

    Analysis of epidemiological characteristics and influencing factors of [LC] among university students in the post-pandemic era, 2026, Guo et al.

    Analysis of epidemiological characteristics and influencing factors of Long COVID syndrome among university students in the post-pandemic era Abstract Objective: To analyze the epidemiological characteristics of Long COVID syndrome in university students during the post-pandemic era...
  3. Chandelier

    The Post-COVID syndrome caused by excessive inflammation: pathogenesis, potential targets and therapeutic agents, 2026, Zhou et al.

    The Post-COVID syndrome caused by excessive inflammation: pathogenesis, potential targets and therapeutic agents Abstract Post-COVID syndrome is predominantly characterized by persistent fatigue that cannot be attributed to other underlying diseases or relieved by conventional rest. Such...
  4. Chandelier

    Long-term impact of COVID-19 on haemophilia: a multicenter study in Southwest China, 2026, Cao et al.

    Long-term impact of COVID-19 on haemophilia: a multicenter study in Southwest China Abstract Background The coronavirus disease 2019 (COVID-19) pandemic is not yet over as millions of people are still diagnosed with persistent symptoms of COVID-19 (long COVID) worldwide. Despite some...
  5. Chandelier

    Preprint Prevalence, trends, and correlates of long COVID in mainland China after the policy shift: findings from two cross-sectional surveys, 2026, Ruan et al

    Prevalence, trends, and correlates of long COVID in mainland China after the policy shift: findings from two cross-sectional surveys Abstract Background The long-term consequences of the Chinese COVID-19 wave in 2022 remain unknown. To clarify the health outcomes of COVID-19 survivors after...
  6. Hutan

    Between Party, People, and Profession: The Many Faces of the ‘Doctor’ during the Cultural Revolution, 2018, Gross et al

    Between Party, People, and Profession: The Many Faces of the ‘Doctor’ during the Cultural Revolution Gross, Miriam Abstract During the Chinese Cultural Revolution (1966–76), Chairman Mao fundamentally reformed medicine so that rural people received medical care. His new medical model has been...
  7. Andy

    Phosphoproteomic analysis reveals differential associations between liver-spleen disharmony and qi-blood deficiency syndromes in [CFS] 2026 Zhang+

    Abstract Background Chronic fatigue syndrome (CFS) is a debilitating disorder characterized by persistent fatigue that is not alleviated by rest and is often accompanied by multiple somatic symptoms. The etiology of CFS remains poorly understood, and conventional Western medicine offers limited...
  8. Andy

    Tactile and interpersonal sound symbolic associations in patients with multiple somatic symptoms 2025 Jiang et al

    Abstract Patients with functional somatic symptoms (FSS) have distorted exteroception and interoception. It is unclear whether they also process and associate sounds and tactile/interpersonal factors differently. This study investigates the differences in how patients with multiple somatic...
  9. Wyva

    Multiple Voxel Pattern Analysis Shows Associations Between Chronic Fatigue Syndrome and Cortical Atrophy, 2025, Wu et al

    Now published - see here ************* Kang Wu, Yihuai Zou, Yuanyuan Li, Xiaojie Hu, Yahui Wang, TZ CHEN, Yuhang Chen, Kuangshi Li Abstract Chronic Fatigue Syndrome (CFS) is a disease characterized by unexplained fatigue and impaired cognition for more than six months. Recent studies have...
  10. Hutan

    News from China

    Surprisingly, we don't have a thread for news from China yet
  11. Yann04

    Preprint Neurasthenia in CCMD (Chinese Classification of Mental Disorders), 2024, Maniscalco

    No Abstract Provided My phone isn’t letting me copy exerpts from pdf. But the reason I’m sharing this is it’s a rather interesting peak into how pwME might be treated in China (it seems a diagnosis of “somatic depression” is likely). LINK (PDF)
  12. Yann04

    Jingfang Granule promotes the tricarboxylic acid cycle to improve chronic fatigue syndrome by increasing the expression of Idh1 and Idh2 2024 Wang+

    ABSTRACT Ethnopharmacological relevance Chronic fatigue syndrome (CFS), as a complex, multisystemic, and multisystemic disorder affecting multiple organs and systems, often accompanies by symptoms such as post-exercise discomfort, sleep disorders, cognitive difficulties, and orthostatic...
  13. Dolphin

    Review Trends and Hotspots in the Health Economics Evaluation of Chronic Fatigue Syndrome, 2024, Wan

    Wan H, Wei B, Qian W, Zhang J. Trends and Hotspots in the Health Economics Evaluation of Chronic Fatigue Syndrome. J Multidiscip Healthc. 2024;17:4877-4892 https://doi.org/10.2147/JMDH.S482100...
  14. Nightsong

    Long COVID facts and findings: a large-scale online survey in 74,075 Chinese participants, 2024, Qin et al

    Background Research on long COVID in China is limited, particularly in terms of large-sample epidemiological data and the effects of recent SARS-CoV-2 sub-variants. China provides an ideal study environment owing to its large infection base, high vaccine coverage, and stringent pre-pandemic...
  15. Wyva

    Immunometabolic changes and potential biomarkers in CFS peripheral immune cells revealed by single-cell RNA sequencing, 2024, Sun et al

    Abstract The pathogenesis of Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) remains unclear, though increasing evidence suggests inflammatory processes play key roles. In this study, single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) was used to...
  16. forestglip

    Review The efficacy of antivirals, corticosteroids, and mAbs as acute COVID treatments in reducing the incidence of long COVID, 2024, Gangqiang +

    The efficacy of antivirals, corticosteroids, and mAbs as acute COVID treatments in reducing the incidence of long COVID: a Systematic Review and meta-analysis Gangqiang Sun, Ke Lin, Jingwen Ai, Wenhong Zhang Abstract Background: Whether treatment during acute COVID results in protective...
  17. Andy

    Review Effects of traditional Chinese mind-body exercises for patients with chronic fatigue syndrome: A systematic review and meta-analysis 2023 Kong et al

    Background: Chronic fatigue syndrome (CFS) is a global public health concern. We performed this systematic review of randomised controlled trials (RCTs) to evaluate the effects and safety of traditional Chinese mind-body exercises (TCME) for patients with CFS. Methods: We comprehensively...
  18. Hutan

    Recent Advancements on Long COVID in China: A Narrative Review, 2023, Tang et al

    https://www.dovepress.com/recent-advancements-on-long-covid-in-china-a-narrative-review-peer-reviewed-fulltext-article-IJGM Abstract: The COVID-19 pandemic is a huge public health crisis in the 21st century. In addition to the acute symptoms, a considerable proportion of patients worldwide have...
  19. Hutan

    A one-year follow-up study of systematic impact of long COVID symptoms ... in Shanghai, China, 2023, Cai et al

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281439/ Long COVID hinders people from normal life and work, posing significant medical and economic challenges. Nevertheless, comprehensive studies assessing its impact on large populations in Asia are still lacking. We tracked over 20,000...
  20. Hutan

    Protocol Phase III Clinical Trial on the Efficacy and Safety of Meplazumab ... in the Treatment of Post-covid-19, 2023

    The actual study start date was March 2023, the estimated primary end date was 1 June 2023 and the estimated study completion date is 1 October 2023. Clinical Trials link: https://clinicaltrials.gov/ct2/show/NCT05813587?term=Meplazumab&draw=2&rank=8 Randomized, double-blind...
Back
Top Bottom